8-KEarnings & ResultsExhibits & Filings

Elevance Health, Inc. 8-K Report, Financial Results (Jul 29, 2015)

Filed July 29, 2015For Securities:ELV

Summary

Elevance Health, Inc. (formerly Anthem, Inc.) filed an 8-K report on July 29, 2015, to announce its financial results for the second quarter ended June 30, 2015. The key information is contained within the press release furnished as an exhibit, which details the company's performance during the quarter. Investors should review this press release for specific figures on revenue, earnings, membership, and any forward-looking guidance provided by the company. This filing serves as the primary channel for disseminating these crucial financial updates to the public market. While the 8-K itself is a brief document, the attached press release is the substance for analysis, offering insights into the operational and financial health of Elevance Health during the specified period. Investors are advised to consult Exhibit 99.1 for comprehensive details on the company's second-quarter performance.

Key Highlights

  • 1Anthem, Inc. (now Elevance Health) announced its second quarter financial results for the period ending June 30, 2015.
  • 2The financial results were disclosed via a press release furnished as Exhibit 99.1 to the 8-K filing.
  • 3The filing is dated July 29, 2015, and reports on events occurring on or before that date.
  • 4The report is filed under Section 2 (Financial Information) and Item 2.02 (Results of Operations and Financial Condition).
  • 5Information furnished under Item 2.02 and Exhibit 99.1 is not considered 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934, limiting liability but also requiring careful interpretation.
  • 6The registrant's principal executive offices are located at 120 Monument Circle, Indianapolis, IN 46204.
  • 7The filing confirms the company's legal name at the time was Anthem, Inc., incorporated in Indiana.

Frequently Asked Questions

The main purpose of this 8-K filing is to officially report Anthem, Inc.'s (now Elevance Health) financial results for the second quarter ended June 30, 2015, to the U.S. Securities and Exchange Commission and the public.

The detailed financial results are provided in the press release dated July 29, 2015, which is furnished as Exhibit 99.1 to this 8-K filing. Investors should refer to this exhibit for specific performance metrics.

The filing itself does not contain forward-looking statements. However, the accompanying press release (Exhibit 99.1) likely includes such information, such as financial guidance for the upcoming quarters or the full year. Investors should carefully review the press release for any forward-looking statements and associated disclaimers.

No, the filing explicitly states that information furnished under Item 2.02 and in Exhibit 99.1 is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934. This means the company has less legal liability for that specific information compared to officially filed documents.